Ozempic maker Novo Nordisk slows Danish growth

Published:

Ozempic maker Novo Nordisk slows Danish growth
Photo: Ida Marie Odgaard/Ritzau

Advertisement

Excluding the country's large pharmaceutical sector, growth in the quarter would have been 1.2 percent.

Denmark's pharmaceutical sector saw a decline of 1.1 percent in the fourth quarter. Last fall, Denmark's central bank lowered its growth forecast for Denmark's economy due to lower expectations for the pharmaceutical industry.

In previous quarters, the pharmaceutical sector has contributed to a boost in GDP. For the full year 2025, the Danish economy grew by 2.9 percent.

Loading related articles...

Author

TT News AgencyT
By TT News AgencyEnglish edition by Sweden Herald, adapted for our readers

Advertisement

Keep reading

Loading related posts...